Clinical trial Recruiting at 1 site Interventional Ages 12 to 19

A system to prevent suicide in Black youth

Official title: Answering the Alarm: A System of Care for Black Youth at Risk for Suicide

Run by New York University · NCT05654207 · Data updated 2026-11-12

This study is testing a new care system called WeCare to see if it can help reduce suicide risk among Black youth by providing better support and screening in emergency departments.

Quick facts

Study typeInterventional
Ages12 Years to 19 Years
SexAll
Enrollment2200 (estimated)
SponsorNew York University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedApril 8, 2024
Main results expectedApril 1, 2027
Study endsApril 1, 2027
Registry record updatedJune 10, 2026
Trial IDNCT05654207 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are Black adolescents aged 12-19 who present to emergency departments with suicidal ideation and have a parent or guardian available to provide consent.

Probably not a fit

Patients who are medically unstable, have severe cognitive impairments, or are currently receiving mental health treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to address the rising rates of suicidal ideation among Black youth by implementing a comprehensive care system called WeCare. The approach includes universal screening for suicide risk using the Computerized Adaptive Screen for Suicidal Youth (CASSY), a brief intervention tailored for Black adolescents in emergency departments, and supportive text messaging for both youth and their caregivers. The study will evaluate the effectiveness of this multi-faceted strategy in improving suicide risk detection and providing necessary support. By integrating input from various stakeholders, the study seeks to enhance the implementation of this intervention.

Why it matters

Potential benefit: If successful, this approach could significantly reduce suicidal ideation and improve mental health outcomes for Black youth.

How similar studies have gone: Other studies have shown promise in using similar multi-component interventions for suicide prevention, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria adolescent and parent/guardians:

* Adolescents aged 12-17 years and their parents or guardians, and adolescents 18-19 years who have the option for their parent or guardian to participate
* Having a parent/caregiver present in the ED to consent or available to consent remotely (12-17 year olds, only)
* Having a cellular phone with text messaging capacity
* Adolescent able to speak English, and understand study questions
* Parents able to consent in English, Spanish, French or Creole
* Meet screening criteria

Exclusion criteria adolescent and parent/guardians:

* Adolescent is medically unstable
* Adolescent present with severe cognitive impairment
* Parents are not present in the ED, unable to consent remotely, and not able to give consent in either English, Spanish, French or Creole (12-17 year olds, only)
* Adolescent does not have access to cellular phone
* Adolescents active in mental health treatment (e.g., seen a therapist, social worker, or mental health provider in the last week)

Where it's running

  • Kings County Hospital
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.